These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1580280)

  • 1. Large artery dilation produced by converting enzyme inhibition in hypertension: therapeutic aspects.
    Safar ME; Asmar RG; Benetos A
    Am J Med; 1992 Apr; 92(4B):47S-53S. PubMed ID: 1580280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hypertension and ACE inhibition on arterial structure and compliance.
    Safar ME; Levy BI
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():29-32. PubMed ID: 1395114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose optimization study of arterial changes associated with angiotensin converting enzyme inhibition in hypertension.
    Asmar RG; Iannascoli F; Benetos A; Safar ME
    J Hypertens Suppl; 1992 Jul; 10(5):S13-9. PubMed ID: 1403229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of converting enzyme inhibitors on hypertensive large arteries in humans.
    Safar ME; Laurent SL; Bouthier JD; London GM; Mimran AR
    J Hypertens Suppl; 1986 Dec; 4(5):S285-9. PubMed ID: 3033179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibition and brachial artery haemodynamics in hypertension.
    Simon AC; Levenson JA; Safar AM; Bouthier JD; Safar ME
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):243S-247S. PubMed ID: 6099739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
    Buus NH; Jørgensen CG; Mulvany MJ; Sørensen KE
    Blood Press; 2007; 16(2):106-13. PubMed ID: 17612909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ramipril on arterial hemodynamics.
    Benetos A; Vasmant D; Thiéry P; Safar M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S153-6. PubMed ID: 1725030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance and conduit arteries following converting enzyme inhibition in hypertension.
    Safar ME; van Bortel LM; Struijker-Boudier HA
    J Vasc Res; 1997; 34(2):67-81. PubMed ID: 9167639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral large arteries and the response to antihypertensive treatment.
    Safar ME; Bouthier JA; Levenson JA; Simon AC
    Hypertension; 1983; 5(5 Pt 2):III63-8. PubMed ID: 6414951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives.
    Tropeano AI; Boutouyrie P; Pannier B; Joannides R; Balkestein E; Katsahian S; Laloux B; Thuillez C; Struijker-Boudier H; Laurent S
    Hypertension; 2006 Jul; 48(1):80-6. PubMed ID: 16702490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries.
    Erzen B; Gradisek P; Poredos P; Sabovic M
    Angiology; 2006; 57(2):187-92. PubMed ID: 16518526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute and chronic angiotensin-converting enzyme inhibition on large arteries in human hypertension.
    Simon AC; Levenson JA; Bouthier J; Maarek B; Safar ME
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S45-51. PubMed ID: 2580176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension.
    Asmar RG; Pannier B; Santoni JP; Laurent S; London GM; Levy BI; Safar ME
    Circulation; 1988 Oct; 78(4):941-50. PubMed ID: 2971473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converting enzyme inhibition and the common carotid circulation in older patients with sustained essential hypertension.
    Safar M; Asmar R; Bouthier J; Lacolley P; Laurent S
    Eur Heart J; 1988 Mar; 9 Suppl D():75-8. PubMed ID: 2967755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effect of antihypertensive drugs on conduit artery endothelial function.
    Ghiadoni L; Magagna A; Versari D; Kardasz I; Huang Y; Taddei S; Salvetti A
    Hypertension; 2003 Jun; 41(6):1281-6. PubMed ID: 12719441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lacidipine on the carotid and cerebral circulations in essential hypertension.
    Safar ME
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S51-4. PubMed ID: 1726008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition and compliance of the carotid artery in normotensive and hypertensive rats.
    Levy BI; Benessiano J; Poitevin P; Safar ME
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():57-62. PubMed ID: 2550645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial structure in hypertension and the effects of angiotensin converting enzyme inhibition.
    Safar ME; Levy BI; London GM
    J Hypertens Suppl; 1992 Jul; 10(5):S51-7. PubMed ID: 1403234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of labetalol on hypertensive brachial artery.
    Pithois-Merli IM; Cournot AX; Georges DR; Pappo M; Safar ME
    J Clin Hypertens; 1987 Dec; 3(4):479-86. PubMed ID: 3453384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.